Kyle Michael Wool Purchases 50,000 Shares of Dominari (NASDAQ:DOMH) Stock

Dominari Holdings Inc. (NASDAQ:DOMH) President Kyle Michael Wool purchased 50,000 shares of the firm’s stock in a transaction on Thursday, September 10th. The shares were purchased at an average cost of $2.02 per share, with a total value of $101,000.00. Following the completion of the purchase, the president owned 4,261,828 shares in the company, valued at $8,608,892.56. This represents a 1.19% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Dominari Stock Performance

Shares of DOMH stock opened at $2.18 on Monday. Dominari Holdings Inc. has a 1 year low of $1.91 and a 1 year high of $8.40. The business’s fifty day moving average is $2.56 and its 200-day moving average is $2.92. The stock has a market cap of $52.84 million, a PE ratio of -0.40 and a beta of 0.87.

Dominari (NASDAQ:DOMH) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.34) by $0.13. Dominari had a negative return on equity of 235.37% and a negative net margin of 51.61%.The business had revenue of $16.79 million during the quarter, compared to analyst estimates of $16.79 million.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Wall Street Zen downgraded shares of Dominari from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Dominari in a research note on Monday, July 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Institutional Investors Weigh In On Dominari

Several hedge funds have recently modified their holdings of the stock. Connective Capital Management LLC raised its holdings in Dominari by 112.9% during the 2nd quarter. Connective Capital Management LLC now owns 243,223 shares of the company’s stock worth $764,000 after buying an additional 128,994 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Dominari by 59.1% in the first quarter. Renaissance Technologies LLC now owns 132,362 shares of the company’s stock worth $430,000 after buying an additional 49,162 shares during the period. PFG Investments LLC boosted its holdings in shares of Dominari by 36.3% in the first quarter. PFG Investments LLC now owns 14,475 shares of the company’s stock worth $47,000 after buying an additional 3,855 shares during the period. Creek Drive Management Group LLC purchased a new position in shares of Dominari in the fourth quarter worth approximately $1,861,000. Finally, NewEdge Advisors LLC acquired a new stake in shares of Dominari during the fourth quarter valued at approximately $50,000. 42.48% of the stock is owned by hedge funds and other institutional investors.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.